Loading data
PSANYSE
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 4.82 bn USD | 4.7 bn USD | 4.52 bn USD | 4.18 bn USD | 3.42 bn USD |
| Interest expense | 304.5 m USD | 287.4 m USD | 201.13 m USD | 136.32 m USD | 90.77 m USD |
| Profit before tax | 1.79 bn USD | 2.09 bn USD | 2.17 bn USD | 4.38 bn USD | 1.97 bn USD |
| Income tax expense | -7.23 m USD | 4.67 m USD | 10.82 m USD | 14.33 m USD | 12.37 m USD |
| Net income (reported basis) | 1.78 bn USD | 2.07 bn USD | 2.15 bn USD | 4.37 m USD | 1.96 m USD |
| Net income attributable to common shareholders | 1.59 bn USD | 1.87 bn USD | 1.95 bn USD | 4.14 bn USD | 1.73 bn USD |
| Basic earnings per share | 9.04 USD/share | 10.68 USD/share | 11.11 USD/share | 23.64 USD/share | 9.91 USD/share |
| Diluted earnings per share | 9.01 USD/share | 10.64 USD/share | 11.06 USD/share | 23.5 USD/share | 9.87 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.